Dupilumab is highly effective in treating atopic dermatitis (AD). However, some patients experience difficulties with dupilumab therapy, such as inadequate clinical response, failure to achieve long-term disease control, or adverse events (AEs). Our objective is to assess inadequate response and AEs occurring in children on dupilumab therapy for AD.

中文翻译：

---

在三级医疗机构 c 中使用 dupilumab 治疗小儿特应性皮炎的经验：反应不足和不良事件

Dupilumab 在治疗特应性皮炎 (AD) 方面非常有效。然而，一些患者在接受 dupilumab 治疗时遇到困难，例如临床反应不足、未能实现长期疾病控制或不良事件 (AE)。我们的目标是评估在 AD 中接受 dupilumab 治疗的儿童中发生的反应不足和 AE。